Dr. Rouchdi Rifai, Detroit Cosmetic Surgery Specialist, is among the first doctors in the nation to offer the VOLUMA treatment. Due to his expertise in his field, he was hand-selected for an early authorization to provide the new filler.
Juvederm VOLUMA was recently approved by the FDA and is the first and only filler approved that temporarily corrects age-related volume loss in cheeks in adults over the age of 21.
In a clinical study conducted by Allergan, 102 patients with facial volume loss each received one treatment of VOLUMA dermal filler. 6 to 18 months after the treatment, an assessment found almost 65% of patients’ facial volume was rated as being ‘very much improved’. And, more than 7 out of 10 patients described their facial volume as being ‘very good’ during 6 to 18 months following the treatment. In addition, VOLUMA is associated with having lower incidences of adverse events and allergic reactions than other facial volumizers.
